{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:01:55Z","timestamp":1648576915079},"reference-count":364,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/bor.0b013e328359ee5b","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T22:10:34Z","timestamp":1348783834000},"page":"694-702","source":"Crossref","is-referenced-by-count":0,"title":["Current World Literature"],"prefix":"10.1097","volume":"24","member":"276","reference":[{"key":"-20210128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1369\/0022155410398000","article-title":"Identification and Molecular Analysis of Glycosaminoglycans in Cutaneous Lupus Erythematosus and Dermatomyositis.","volume":"59","author":"Chang","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study.","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis.","volume":"65","author":"Goreshi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2230.2011.04188.x","article-title":"Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions.","volume":"37","author":"Hornung","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1369\/0022155411411304","article-title":"Identification of Specific Chondroitin Sulfate Species in Cutaneous Autoimmune Disease.","volume":"59","author":"Kim","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"C18","DOI":"10.12968\/hmed.2012.73.Sup2.C18","article-title":"Dermatomyositis.","volume":"73","author":"Mahil","year":"2012","journal-title":"Br J Hosp Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/rheumatology\/keq430","article-title":"Association between nail-fold capillary findings and disease activity in dermatomyositis.","volume":"50","author":"Mugii","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of Adult and Juvenile Dermatomyositis, Polymyositis, and Inclusion Body Myositis Physician and PatientParent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-11-143","article-title":"Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China - art. no. 143.","volume":"11","author":"Shu","year":"2011","journal-title":"BMC Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3899\/jrheum.110320","article-title":"Idiopathic Inflammatory Myopathy Associated with Malignancy: A Retrospective Cohort of 151 Korean Patients with Dermatomyositis and Polymyositis.","volume":"38","author":"So","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-010-1745-2","article-title":"Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital.","volume":"32","author":"Teh","year":"2012","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.berh.2012.01.013","article-title":"Idiopathic inflammatory myopathies.","volume":"26","author":"Vincze","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1468-3083.2010.03929.x","article-title":"Dermatomyositis related to autoimmune thyroiditis.","volume":"25","author":"Wang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan.","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.rdc.2011.09.007","article-title":"Paraneoplastic Myalgias and Myositis.","volume":"37","author":"Aggarwal","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of Anti-Signal Recognition Particle Autoantibody Levels With Creatine Kinase Activity in Patients With Necrotizing Myopathy.","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","article-title":"Novel autoantibodies and clinical phenotypes in adult and juvenile myositis - art. no. 209.","volume":"13","author":"Betteridge","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1470.2011.01501.x","article-title":"Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use.","volume":"28","author":"Chiu","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar3347","article-title":"The lung as a possible target for the immune reaction in myositis - art. no. 230.","volume":"13","author":"Danoff","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.revmed.2011.11.017","article-title":"Antisynthetase syndrome: A retrospective study of 14 patients.","volume":"33","author":"Dieval","year":"2012","journal-title":"Rev Med Interne"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.revmed.2011.11.018","article-title":"Inflammatory myopathies, autoimmune necrotizing myopathies and adult-onset genetic myopathies: Differential diagnosis.","volume":"33","author":"Dimitri","year":"2012","journal-title":"Rev Med Interne"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1750-3639.2011.00510.x","article-title":"Gain and Loss of Extracellular Molecules in Sporadic Inclusion Body Myositis and PolymyositisuA Proteomics-Based Study.","volume":"22","author":"Doppler","year":"2012","journal-title":"Brain Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.22279","article-title":"Necrotizing myopathy: Clinicoserologic associations.","volume":"45","author":"Ellis","year":"2012","journal-title":"Muscle Nerve"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study.","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155140 autoantibodies target transcription intermediary factor 1 family proteins.","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-010-8238-7","article-title":"Cutting Edge Issues in Polymyositis.","volume":"41","author":"Ghirardello","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis.","volume":"65","author":"Goreshi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","article-title":"Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients.","volume":"38","author":"Ikeda","year":"2011","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nmd.2011.06.751","article-title":"Acetylcholine receptor antibodies in patients with genetic myopathies: Clinical and biological significance.","volume":"22","author":"Lane","year":"2012","journal-title":"Neuromusc Disord"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0b013e32834b324b","article-title":"Necrotizing autoimmune myopathy.","volume":"23","author":"Liang","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00296-010-1637-5","article-title":"A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.","volume":"32","author":"Limaye","year":"2012","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1021\/pr200397h","article-title":"Mass Spectrometric Determination of IgG Subclass-Specific Glycosylation Profiles in Siblings Discordant for Myositis Syndromes.","volume":"10","author":"Perdivara","year":"2011","journal-title":"J Proteome Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification.","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/BOR.0b013e32834b41d2","article-title":"An update on pathogenic mechanisms of inflammatory myopathies.","volume":"23","author":"Rayavarapu","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory Myopathies With Anti-Ku Antibodies A Prognosis Dependent on Associated Lung Disease.","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-011-8286-7","article-title":"Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders.","volume":"42","author":"Satoh","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar3334","article-title":"Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study - art. no. R73.","volume":"13","author":"Satoh","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","article-title":"Anti-Signal Recognition Particle Myopathy in the First Decade of Life.","volume":"45","author":"Suzuki","year":"2011","journal-title":"Pediatr Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis.","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1139\/o11-055","article-title":"Oxidative stress-induced modifications of histidyl-tRNA synthetase affect its tRNA aminoacylation activity but not its immunoreactivity.","volume":"89","author":"van Dooren","year":"2011","journal-title":"Biochem Cell Biol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan.","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/BOR.0b013e32834b5457","article-title":"State of the art: what we know about infectious agents and myositis.","volume":"23","author":"Gan","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","article-title":"Inclusion Body Myositis Laser Microdissection Reveals Differential Up-Regulation of IFN-gamma Signaling Cascade in Attacked versus Nonattacked Myofibers.","volume":"179","author":"Ivanidze","year":"2011","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1097\/INF.0b013e318217e356","article-title":"A Large Outbreak of Influenza B-associated Benign Acute Childhood Myositis in Germany, 20072008.","volume":"30","author":"Mall","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.micinf.2011.12.008","article-title":"Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model.","volume":"14","author":"Patil","year":"2012","journal-title":"Microbes Infect"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.33350","article-title":"Immature muscle precursors are a source of interferon-ss in myositis: Role of toll-like receptor 3 activation and contribution to HLA class I up-regulation.","volume":"64","author":"Tournadre","year":"2012","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a US managed care plan.","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MCO.0b013e328352694f","article-title":"Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features.","volume":"15","author":"Jeejeebhoy","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis.","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/bjc.2011.391","article-title":"Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia.","volume":"105","author":"Murphy","year":"2011","journal-title":"Br J Cancer"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma.","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.berh.2012.01.013","article-title":"Idiopathic inflammatory myopathies.","volume":"26","author":"Vincze","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12603-011-0366-0","article-title":"Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction.","volume":"15","author":"Abbatecola","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ageing\/afr040","article-title":"Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women.","volume":"40","author":"Aleman","year":"2011","journal-title":"Age Ageing"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2011.05.014","article-title":"Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in Aging.","volume":"14","author":"Andersson","year":"2011","journal-title":"Cell Metab"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.NAJ.0000408184.21770.98","article-title":"Sarcopenic Obesity: Strategies for Management.","volume":"111","author":"Benton","year":"2011","journal-title":"Am J Nurs"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCO.0b013e32834dd297","article-title":"Chronic low-grade inflammation and age-related sarcopenia.","volume":"15","author":"Beyer","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"-20210128","first-page":"4201","article-title":"Aging, sarcopenia and store-operated calcium entry A common link Cell C","volume":"10","author":"Brotto","year":"2011","journal-title":"ycle"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cll.2011.03.009","article-title":"Desmoplastic Melanoma.","volume":"31","author":"Busam","year":"2011","journal-title":"Clin Lab Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10522-011-9327-6","article-title":"Sarcopenia: current theories and the potential beneficial effect of creatine application strategies.","volume":"12","author":"Candow","year":"2011","journal-title":"Biogerontology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/gerona\/glr042","article-title":"Usefulness of Preclinical Models for Assessing the Efficacy of Late-Life Interventions for Sarcopenia.","volume":"67","author":"Carter","year":"2012","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ageing\/afr167","article-title":"Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease.","volume":"41","author":"Cesari","year":"2012","journal-title":"Age Ageing"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2474-12-246","article-title":"Non-invasive muscle contraction assay to study rodent models of sarcopenia - art. no. 246.","volume":"12","author":"Chiu","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12603-011-0092-7","article-title":"International working group on Sarcopenia.","volume":"15","author":"Chumlea","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MCO.0b013e32834da629","article-title":"Bedrest and sarcopenia.","volume":"15","author":"Coker","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"C1226","DOI":"10.1152\/ajpcell.00354.2010","article-title":"Age-related impairment of T cell-induced skeletal muscle precursor cell function.","volume":"300","author":"Dumke","year":"2011","journal-title":"Am J Physiol-Cell Physiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia.","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0031-1297953","article-title":"Physical Inactivity is a Major Contributor to Ovariectomy-Induced Sarcopenia.","volume":"33","author":"Fonseca","year":"2012","journal-title":"Int J Sports Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pmr.2011.11.012","article-title":"Aging of Human Muscle: Understanding Sarcopenia at the Single Muscle Cell Level.","volume":"23","author":"Frontera","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-010-8238-7","article-title":"Cutting Edge Issues in Polymyositis.","volume":"41","author":"Ghirardello","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"-20210128","first-page":"1184","article-title":"A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolism DISCUSSION.","volume":"150","author":"Hodin","year":"2011","journal-title":"Surgery"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/gerona\/glr047","article-title":"Long-Term Supplementation With Resveratrol Alleviates Oxidative Stress but Does Not Attenuate Sarcopenia in Aged Mice.","volume":"66","author":"Jackson","year":"2011","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/gerona\/glr072","article-title":"Identification of Novel Genes Involved in Sarcopenia Through RNAi Screening in Caenorhabditis elegans.","volume":"67","author":"Kashyap","year":"2012","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/ndt\/gfq652","article-title":"Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.","volume":"26","author":"Kato","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1210\/jc.2011-1602","article-title":"Vitamin D Deficiency Is Associated with Sarcopenia in Older Koreans, Regardless of Obesity: The Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009.","volume":"96","author":"Kim","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1532-5415.2011.03664.x","article-title":"Depression Is Associated with Sarcopenia, Not Central Obesity, in Elderly Korean Men.","volume":"59","author":"Kim","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gaitpost.2011.09.003","article-title":"Sarcopenia and predictors of the fat free mass index in community-dwelling and assisted-living older men and women.","volume":"35","author":"Krause","year":"2012","journal-title":"Gait Posture"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocd.2011.08.007","article-title":"Impact of a New Sarco-Osteopenia Definition on Health-related Quality of Life in a Population-Based Cohort in Northern Europe.","volume":"15","author":"Kull","year":"2012","journal-title":"J Clin Densitom"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/gerona\/glr035","article-title":"Prevalence and Risk Factors of Sarcopenia Among Nursing Home Older Residents.","volume":"67","author":"Landi","year":"2012","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jamda.2011.07.004","article-title":"Sarcopenia and Mortality among Older Nursing Home Residents.","volume":"13","author":"Landi","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1089\/ars.2011.3974","article-title":"Living in a Box or Call of the Wild Revisiting Lifetime Inactivity and Sarcopenia.","volume":"15","author":"Lawler","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.maturitas.2011.11.012","article-title":"Sarcopenia in the elderly: Diagnosis, physiopathology and treatment.","volume":"71","author":"Malafarina","year":"2012","journal-title":"Maturitas"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12603-011-0108-3","article-title":"Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain).","volume":"16","author":"Masanes","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis.","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/fampra\/cmr063","article-title":"Sarcopenia in the elderly.","volume":"29","author":"Morley","year":"2012","journal-title":"Fam Pr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Sarcopenia With Limited Mobility: An International Consensus.","volume":"12","author":"Morley","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ajpath.2011.12.027","article-title":"TWEAK in Inclusion-Body Myositis Muscle Possible Pathogenic Role of a Cytokine Inhibiting Myogenesis.","volume":"180","author":"Morosetti","year":"2012","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exger.2011.11.007","article-title":"Cumulative 3-nitrotyrosine in specific muscle proteins is associated with muscle loss during aging.","volume":"47","author":"Murakami","year":"2012","journal-title":"Exp Gerontol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10522-011-9336-5","article-title":"Human myotubes from myoblast cultures undergoing senescence exhibit defects in glucose and lipid metabolism.","volume":"12","author":"Nehlin","year":"2011","journal-title":"Biogerontology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12192-011-0310-6","article-title":"Plasma heat shock protein 72 as a biomarker of sarcopenia in elderly people.","volume":"17","author":"Ogawa","year":"2012","journal-title":"Cell Stress Chaperones"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1590\/S0100-879X2011007500135","article-title":"Identification of sarcopenic obesity in postmenopausal women: a cutoff proposal.","volume":"44","author":"Oliveira","year":"2011","journal-title":"Brazilian J Med Biol Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12603-011-0058-9","article-title":"Designing phase ii b trials in sarcopenia: the best target population.","volume":"15","author":"Pahor","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/gerona\/glr020","article-title":"Developmental Influences, Muscle Morphology, and Sarcopenia in Community-Dwelling Older Men.","volume":"67","author":"Patel","year":"2012","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cld.2011.12.009","article-title":"Malnutrition in Cirrhosis: Contribution and Consequences of Sarcopenia on Metabolic and Clinical Responses.","volume":"16","author":"Periyalwar","year":"2012","journal-title":"Clin Liver Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cger.2011.03.009","article-title":"Physical Activity and Sarcopenia.","volume":"27","author":"Pillard","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/gerona\/glr025","article-title":"Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men.","volume":"66","author":"Ratkevicius","year":"2011","journal-title":"J Gerontol Ser A-Biol Sci Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"XI","DOI":"10.1016\/j.cger.2011.04.002","article-title":"Sarcopenia Preface.","volume":"27","author":"Rolland","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mcna.2011.02.008","article-title":"Treatment Strategies for Sarcopenia and Frailty.","volume":"95","author":"Rolland","year":"2011","journal-title":"Med Clin N Am"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cger.2011.03.008","article-title":"Current and Future Pharmacologic Treatment of Sarcopenia.","volume":"27","author":"Rolland","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cger.2011.03.003","article-title":"Sarcopenia: Origins and Clinical Relevance.","volume":"27","author":"Rosenberg","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","first-page":"660","article-title":"Accumulation of severely atrophic myofibers marks the acceleration of sarcopenia in slow and fast twitch muscles.","volume":"46","author":"Rowan","year":"2011","journal-title":"Exp Gerontol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma.","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exger.2011.08.012","article-title":"The loss of muscle mass and sarcopenia: Non hormonal intervention.","volume":"46","author":"Sanchis-Gomar","year":"2011","journal-title":"Exp Gerontol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e32834884e6","article-title":"Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.","volume":"25","author":"Scherzer","year":"2011","journal-title":"Aids"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/acr.20545","article-title":"Prospective study of self-reported pain, radiographic osteoarthritis, sarcopenia progression, and falls risk in community-dwelling older adults.","volume":"64","author":"Scott","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1532-5415.2012.03887.x","article-title":"Association Between Visceral Obesity and Sarcopenia and Vitamin D Deficiency in Older Koreans: The Ansan Geriatric Study.","volume":"60","author":"Seo","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10522-011-9365-0","article-title":"Age-related loss of muscle fibres is highly variable amongst mouse skeletal muscles.","volume":"13","author":"Sheard","year":"2012","journal-title":"Biogerontology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2516.2011.02616.x","article-title":"Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius.","volume":"18","author":"Soucek","year":"2012","journal-title":"Haemophilia"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-011-1040-7","article-title":"Molecular genetic studies of gene identification for sarcopenia.","volume":"131","author":"Tan","year":"2012","journal-title":"Hum Genet"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1532-5415.2011.03512.x","article-title":"Relevant outcomes in intervention trials for sarcopenia.","volume":"59","author":"Van dewoude MFJ, C Cederholm","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12603-011-0365-1","article-title":"Sarcopenia: biomarkers and imaging (international conference on sarcopenia research).","volume":"15","author":"Van Kan","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cger.2011.03.010","article-title":"Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials.","volume":"27","author":"van Kan","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cger.2011.03.006","article-title":"Consequences of Sarcopenia.","volume":"27","author":"Visser","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cger.2011.03.005","article-title":"Physiopathological Mechanism of Sarcopenia.","volume":"27","author":"Walrand","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12603-011-0364-2","article-title":"Pro-dromal sarcopenia.","volume":"15","author":"Waters","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cger.2011.03.007","article-title":"Sarcopenia and Obesity.","volume":"27","author":"Waters","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"-20210128","first-page":"847","article-title":"Are current definitions of sarcopenia applicable for older chinese adults J Nutr Health A","volume":"15","author":"Wen","year":"2011","journal-title":"ging"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-011-0927-7","article-title":"Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinsons disease.","volume":"123","author":"Wrede","year":"2012","journal-title":"Acta Neuropathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar3327","article-title":"Recent advances in the immunogenetics of idiopathic inflammatory myopathy - art. no. 216.","volume":"13","author":"Chinoy","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/ker379","article-title":"Genetic association study of NF-kappa B genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy.","volume":"51","author":"Chinoy","year":"2012","journal-title":"Rheumatology"},{"key":"-20210128","first-page":"154","article-title":"Expression of B7-homolog 1 in Polymyositis.","volume":"41","author":"Duan","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e32834b53cc","article-title":"Inclusion body myositis.","volume":"23","author":"Greenberg","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/BOR.0b013e32834b41d2","article-title":"An update on pathogenic mechanisms of inflammatory myopathies.","volume":"23","author":"Rayavarapu","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0b013e32834f19f5","article-title":"Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies.","volume":"24","author":"Alexanderson","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/art.30530","article-title":"The Role of TRAIL in Mediating Autophagy in Myositis Skeletal Muscle A Potential Nonimmune Mechanism of Muscle Damage.","volume":"63","author":"Alger","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group.","volume":"70","author":"Amato","year":"2011","journal-title":"Ann Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis.","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0309364610389352","article-title":"Stance control orthosis trial in patients with inclusion body myositis.","volume":"35","author":"Bernhardt","year":"2011","journal-title":"Prosthet Orthot Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1470.2011.01501.x","article-title":"Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use.","volume":"28","author":"Chiu","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/rheumatology\/ker305","article-title":"Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry.","volume":"50","author":"Couderc","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target.","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-011-0874-3","article-title":"Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis.","volume":"122","author":"DAgostino","year":"2011","journal-title":"Acta Neuropathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0b013e32834a9589","article-title":"Inflammatory myopathies: management of steroid resistance.","volume":"24","author":"Dalakas","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1186\/ar3540","article-title":"Regenerative potential of human muscle stem cells in chronic inflammation - art. no. R207.","volume":"13","author":"Duijnisveld","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/mus.22222","article-title":"A case of acute sarcoid myositis treated with weekly low-dose methotrexate.","volume":"44","author":"Fujita","year":"2011","journal-title":"Muscle Nerve"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-010-8238-7","article-title":"Cutting Edge Issues in Polymyositis.","volume":"41","author":"Ghirardello","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.mehy.2011.07.007","article-title":"Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.","volume":"77","author":"Glueck","year":"2011","journal-title":"Med Hypotheses"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1152\/ajpendo.00321.2011","article-title":"Intragastric protein administration stimulates overnight muscle protein synthesis in elderly men.","volume":"302","author":"Groen","year":"2012","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/rheumatology\/ker292","article-title":"Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy-a systematic review.","volume":"50","author":"Habers","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/brain\/awr258","article-title":"Update on sporadic inclusion body myositis.","volume":"134","author":"Hohlfeld","year":"2011","journal-title":"Brain"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5414\/NP300395","article-title":"Non-necrotizing autoimmune myopathy with pipestem type capillaries - a light and electron microscopic study.","volume":"31","author":"Janzen","year":"2012","journal-title":"Clin Neuropathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mad.2011.02.007","article-title":"Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages.","volume":"132","author":"Kandalla","year":"2011","journal-title":"Mech Ageing Dev"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1111\/j.1445-5994.2011.02702.x","article-title":"Efficacy of rituximab in refractory antisynthetase syndrome.","volume":"42","author":"Limaye","year":"2012","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0404.2011.01584.x","article-title":"Prognosis and prognostic factors in sporadic inclusion body myositis.","volume":"125","author":"Lindberg","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","article-title":"Rituximab treatment in patients with refractory inflammatory myopathies.","volume":"50","author":"Mahler","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/BOR.0b013e32834ba787","article-title":"Clinical trials roundup in idiopathic inflammatory myopathies.","volume":"23","author":"Mann","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies.","volume":"71","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/ker152","article-title":"Therapeutic effect of tocilizumab on two patients with polymyositis.","volume":"50","author":"Narazaki","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","first-page":"469","article-title":"Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution Rheumatol I","volume":"32","author":"Recher","year":"2012","journal-title":"nt"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10072-011-0657-6","article-title":"Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis.","volume":"32","author":"Sancricca","year":"2011","journal-title":"Neurol Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00115-010-2970-3","article-title":"Standard treatment for myositis and muscular dystrophies.","volume":"82","author":"Schmidt","year":"2011","journal-title":"Nervenarzt"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1098\/rstb.2011.0027","article-title":"Stem cells for skeletal muscle repair.","volume":"366","author":"Shadrach","year":"2011","journal-title":"Philos Trans R Soc B-Biol Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-11-143","article-title":"Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China - art. no. 143.","volume":"11","author":"Shu","year":"2011","journal-title":"BMC Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00415-011-5907-2","article-title":"Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.","volume":"258","author":"Stubgen","year":"2011","journal-title":"J Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","article-title":"Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis.","volume":"70","author":"Wang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1470.2011.01501.x","article-title":"Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use.","volume":"28","author":"Chiu","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","article-title":"Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system.","volume":"50","author":"Davis","year":"2011","journal-title":"Rheumatology"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/art.30475","article-title":"Therapeutic Approaches in the Treatment of Juvenile Dermatomyositis in Patients With Recent-Onset Disease and in Those Experiencing Disease Flare An International Multicenter PRINTO Study.","volume":"63","author":"Hasija","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pediatrneurol.2011.01.018","article-title":"Idiopathic Inflammatory Myopathies in Childhood: A Brief Review of 27 Cases.","volume":"45","author":"Lorenzoni","year":"2011","journal-title":"Pediatr Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"C18","DOI":"10.12968\/hmed.2012.73.Sup2.C18","article-title":"Dermatomyositis.","volume":"73","author":"Mahil","year":"2012","journal-title":"Br J Hosp Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jpeds.2011.03.045","article-title":"Transient Creatine Phosphokinase Elevations in Children: A Single-Center Experience.","volume":"159","author":"Perreault","year":"2011","journal-title":"J Pediatr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of Adult and Juvenile Dermatomyositis, Polymyositis, and Inclusion Body Myositis Physician and PatientParent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1007\/s00228-010-0937-8","article-title":"Criteria to define response to therapy in paediatric rheumatic diseases.","volume":"67","author":"Ruperto","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"-20210128","first-page":"846","article-title":"Venous thromboembolism in patients with dermatomyositis and polymyositis.","volume":"29","author":"Selva-OCallaghan","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-11-143","article-title":"Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China - art. no. 143.","volume":"11","author":"Shu","year":"2011","journal-title":"BMC Neurol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-010-1745-2","article-title":"Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital.","volume":"32","author":"Teh","year":"2012","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.berh.2012.01.013","article-title":"Idiopathic inflammatory myopathies.","volume":"26","author":"Vincze","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00296-010-1615-y","article-title":"MicroRNA array analysis of microRNAs related to systemic scleroderma.","volume":"32","author":"Li","year":"2012","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00296-011-1803-4","article-title":"Atypical presentation of scleroderma in infancy.","volume":"32","author":"Mishra","year":"2012","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00296-010-1532-0","article-title":"A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients with systemic sclerosis.","volume":"31","author":"Muroi","year":"2011","journal-title":"Rheumatol Int"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1259\/dmfr\/64340754","article-title":"Early diagnosis of progressive systemic sclerosis (scleroderma) from a panoramic view: report of three cases.","volume":"40","author":"Anbiaee","year":"2011","journal-title":"Dentomaxillofac Radiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00109-011-0788-5","article-title":"From oncoproteinstumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.","volume":"89","author":"Paulin","year":"2011","journal-title":"J Mol Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3899\/jrheum.110499","article-title":"Effect of Bosentan on Systemic Sclerosis-associated Interstitial Lung Disease Ineligible for Cyclophosphamide Therapy: A Prospective Open-label Study.","volume":"38","author":"Furuya","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/art.30386","article-title":"Role of Semaphorin 7a Signaling in Transforming Growth Factor beta 1-Induced Lung Fibrosis and Scleroderma-Related Interstitial Lung Disease.","volume":"63","author":"Gan","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","first-page":"79","article-title":"Pulmonary involvement in systemic scleroderma.","volume":"195","author":"Guillevin","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"-20210128","first-page":"90","article-title":"Pulmonary involvement in systemic scleroderma DISCUSSION.","volume":"195","author":"Hauw","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease Analysis of the Scleroderma Lung Study Placebo Group.","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00330-011-2223-2","article-title":"Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.","volume":"21","author":"Kim","year":"2011","journal-title":"Eur Radiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-1596-6-50","article-title":"Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: Case report and review of literature - art. no. 50.","volume":"6","author":"Lunardi","year":"2011","journal-title":"Diagn Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.berh.2011.11.007","article-title":"Emerging targeted therapies in scleroderma lung and skin fibrosis.","volume":"25","author":"Maurer","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MAJ.0b013e3181f0b0b4","article-title":"Scleroderma: The Need for Extreme Remedies.","volume":"342","author":"Olsen","year":"2011","journal-title":"Am J Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/art.30438","article-title":"Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung Disease.","volume":"63","author":"Roth","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10067-011-1823-1","article-title":"Effect of mycophenolate sodium in scleroderma-related interstitial lung disease.","volume":"30","author":"Simeon-Aznar","year":"2011","journal-title":"Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","first-page":"S66","article-title":"Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.","volume":"29","author":"Tan","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.ajpath.2011.02.009","article-title":"Fussel-15, a New Player in Wound Healing, Is Deregulated in Keloid and Localized Scleroderma.","volume":"178","author":"Arndt","year":"2011","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10157-011-0419-z","article-title":"A case of slowly progressive scleroderma kidney.","volume":"15","author":"Okabe","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","article-title":"Survival in scleroderma: results from the population-based South Australian Register.","volume":"41","author":"Hissaria","year":"2011","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/RHU.0b013e31822be61e","article-title":"Scleroderma Renal Crisis-Like Acute Renal Failure Associated With Mucopolysaccharide Accumulation in Renal Vessels in a Patient With Scleromyxedema.","volume":"17","author":"Lee","year":"2011","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MAJ.0b013e3181f0b0b4","article-title":"Scleroderma: The Need for Extreme Remedies.","volume":"342","author":"Olsen","year":"2011","journal-title":"Am J Med Sci"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.berh.2012.01.011","article-title":"Scleroderma - New aspects in pathogenesis and treatment.","volume":"26","author":"Balbir-Gurman","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1074\/jbc.M111.286443","article-title":"The p65 Subunit of NF-kappa B Inhibits COL1A1 Gene Transcription in Human Dermal and Scleroderma Fibroblasts through Its Recruitment on Promoter by Protein Interaction with Transcriptional Activators (c-Krox, Sp1, and Sp3).","volume":"287","author":"Beauchef","year":"2012","journal-title":"J Biol Chem"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.30262","article-title":"Amelioration of Dermal Fibrosis by Genetic Deletion or Pharmacologic Antagonism of Lysophosphatidic Acid Receptor 1 in a Mouse Model of Scleroderma.","volume":"63","author":"Castelino","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0398-0499(11)70001-4","article-title":"Updates from the 45th Congress of French College for Vascular Disease (CFPV).","volume":"36","author":"Lazareth","year":"2011","journal-title":"J Mal Vasc"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.ajpath.2011.02.009","article-title":"Fussel-15, a New Player in Wound Healing, Is Deregulated in Keloid and Localized Scleroderma.","volume":"178","author":"Arndt","year":"2011","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/art.30266","article-title":"Methotrexate in Juvenile Localized Scleroderma: Adding to the Evidence.","volume":"63","author":"Foeldvari","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0560.2012.01889.x","article-title":"Alopecia with perineural lymphocytes: a clue to linear scleroderma en coup de sabre.","volume":"39","author":"Goh","year":"2012","journal-title":"J Cutan Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0009922810396546","article-title":"Presentations and Treatment of Childhood Scleroderma: Localized Scleroderma, Eosinophilic Fasciitis, Systemic Sclerosis, and Graft-Versus-Host Disease.","volume":"50","author":"Hedrich","year":"2011","journal-title":"Clin Pediatr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1346-8138.2010.01162.x","article-title":"Digital image processing for the acquisition of graphic similarity of the distributional patterns between cutaneous lesions of linear scleroderma and Blaschkos lines.","volume":"38","author":"Jue","year":"2011","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1097\/SCS.0b013e3182418ce8","article-title":"Treatment of En Coup de Sabre Deformity With Adipose-Derived Regenerative Cell-Enriched Fat Graft.","volume":"23","author":"Karaaltin","year":"2012","journal-title":"J Craniofac Surg"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1346-8138.2010.01191.x","article-title":"Case of juvenile localized scleroderma with joint sclerosis and Sjogrens syndrome in a child with precocious puberty.","volume":"38","author":"Kim","year":"2011","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features.","volume":"55","author":"Kurzinski","year":"2011","journal-title":"Cytokine"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/acr.20407","article-title":"Initial Evaluation of an Ultrasound Measure for Assessing the Activity of Skin Lesions in Juvenile Localized Scleroderma.","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1600-0412.2011.01183.x","article-title":"Botulinum toxin type A for treatment of dyspareunia caused by localized scleroderma.","volume":"90","author":"Mousty","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archdermatol.2011.243","article-title":"14-MHz Ultrasonography as an Outcome Measure in Morphea (Localized Scleroderma).","volume":"147","author":"Nezafati","year":"2011","journal-title":"Arch Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1684\/ejd.2011.1342","article-title":"Localized scleroderma en coup de sabre exacerbated during pregnancy followed by postpartum development of rheumatoid arthritis.","volume":"21","author":"Noda","year":"2011","journal-title":"Eur J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.medcli.2011.03.014","article-title":"Clinical features and prognosis of patients with scleroderma renal crisis.","volume":"137","author":"Roda-Safont","year":"2011","journal-title":"Med Clin"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1016\/j.jaad.2010.11.033","article-title":"Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib.","volume":"66","author":"Runger","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-4632.2010.04843.x","article-title":"Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma.","volume":"50","author":"Su","year":"2011","journal-title":"Int J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.110210","article-title":"Methotrexate and Corticosteroids in the Treatment of Localized Scleroderma: A Standardized Prospective Longitudinal Single-center Study.","volume":"39","author":"Torok","year":"2012","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma.","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate Treatment in Juvenile Localized Scleroderma A Randomized, Double-Blind, Placebo-Controlled Trial.","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arbres.2011.10.008","article-title":"Polymorphisms in the Serotonin Transporter Protein (SERT) Gene in Patients With Pulmonary Arterial Hypertension.","volume":"48","author":"Baloira","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.111.038125","article-title":"Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.","volume":"125","author":"Cahill","year":"2012","journal-title":"Circulation"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A Novel Murine Model of Severe Pulmonary Arterial Hypertension.","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/acr.20693","article-title":"Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.","volume":"64","author":"Fischer","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/RHU.0b013e31824a4d4b","article-title":"Prepatellar and Preolecranon Subcutaneous Calcifications in Scleroderma.","volume":"18","author":"Gonzalez","year":"2012","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RHU.0b013e31824a4d4b","article-title":"Prepatellar and Preolecranon Subcutaneous Calcifications in Scleroderma (vol 18, pg 211, 2012).","volume":"18","author":"Gonzalez","year":"2012","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3899\/jrheum.101243","article-title":"Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study Population.","volume":"38","author":"Hinchcliff","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3899\/jrheum.110397","article-title":"Pulmonary Arterial Hypertension in Systemic Sclerosis Is Associated with Profound Impairment of Microvascular Endothelium-dependent Vasodilatation.","volume":"39","author":"Hofstee","year":"2012","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cvr\/cvr232","article-title":"Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.","volume":"92","author":"Jerkic","year":"2011","journal-title":"Cardiovasc Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in Systemic Sclerosis-associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment for Uncommon Disease.","volume":"39","author":"Johnson","year":"2012","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijcard.2011.05.066","article-title":"Current pathophysiological concepts and management of pulmonary hypertension.","volume":"155","author":"Lourenco","year":"2012","journal-title":"Int J Cardiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000329594","article-title":"Development and Characterization of an Animal Model of Severe Pulmonary Arterial Hypertension.","volume":"49","author":"Morimatsu","year":"2012","journal-title":"J Vasc Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension Results of a Network Bioinformatics Approach.","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00109-011-0788-5","article-title":"From oncoproteinstumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.","volume":"89","author":"Paulin","year":"2011","journal-title":"J Mol Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.201106-1093OC","article-title":"Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension.","volume":"185","author":"Pullamsetti","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1164\/rccm.201108-1536PP","article-title":"Targeting Energetic Metabolism A New Frontier in the Pathogenesis and Treatment of Pulmonary Hypertension.","volume":"185","author":"Tuder","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/BOR.0b013e32834ba6a7","article-title":"Pulmonary hypertension: screening and evaluation in scleroderma.","volume":"23","author":"York","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.111.034512","article-title":"A Critical Role for the Protein Apoptosis Repressor With Caspase Recruitment Domain in Hypoxia-Induced Pulmonary Hypertension.","volume":"124","author":"Zaiman","year":"2011","journal-title":"Circulation"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1753193411433509","article-title":"Fingertip necrosis in a 6-year-old child with primary Raynauds phenomenon.","volume":"37E","author":"Bhat","year":"2012","journal-title":"J Hand Surg-Eur Vol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbspin.2010.11.005","article-title":"Management of Raynauds phenomenon and digital ulcers in systemic sclerosis.","volume":"78","author":"Botzoris","year":"2011","journal-title":"Joint Bone Spine"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ddr.20483","article-title":"Bosentan treatment of digital ulcers related to autoimmune disorders.","volume":"72","author":"Cantisani","year":"2011","journal-title":"Drug Dev Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jvs.2011.01.069","article-title":"Thoracic sympathectomy for digital ischemia: A summary of evidence.","volume":"54","author":"Coveliers","year":"2011","journal-title":"J Vasc Surg"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","article-title":"Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry.","volume":"71","author":"Denton","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"-20210128","first-page":"416","article-title":"Can end organ damage in scleroderma be predicted based on nail fold dermatoscopy findings J D","volume":"39","author":"Dogan","year":"2012","journal-title":"ermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens.","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.e289","article-title":"Diagnosis and management of Raynauds phenomenon - art. no. e289.","volume":"344","author":"Goundry","year":"2012","journal-title":"Br Med J"},{"key":"-20210128","first-page":"493","article-title":"Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers.","volume":"30","author":"Hafner","year":"2011","journal-title":"Int Angiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10067-011-1727-0","article-title":"The association of Raynauds syndrome with rheumatoid arthritis-a meta-analysis.","volume":"30","author":"Hartmann","year":"2011","journal-title":"Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/BOR.0b013e32834aa40b","article-title":"Contemporary management of Raynauds phenomenon and digital ischaemic complications.","volume":"23","author":"Herrick","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.apmr.2011.01.022","article-title":"Effectiveness of Interventions for Secondary Raynauds Phenomenon: A Systematic Review.","volume":"92","author":"Huisstede","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.bjps.2011.05.017","article-title":"Classification of Raynauds disease based on angiographic features.","volume":"64","author":"Kim","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"-20210128","first-page":"622","article-title":"Recent advances in Raynauds syndrome.","volume":"137","author":"Klein-Weigel","year":"2012","journal-title":"Dtsch Med Wochenschr"},{"key":"-20210128","first-page":"NIL1","article-title":"Peripheral nerve changes assessed by conduction velocity distribution in patients with primary Raynauds phenomenon and dysautonomia (vol 30, pg 375, 2011).","volume":"30","author":"Koszewicz","year":"2011","journal-title":"Int Angiol"},{"key":"-20210128","first-page":"375","article-title":"Peripheral nerve changes assessed by conduction velocity distribution in patients with primary Raynauds phenomenon and dysautonomia.","volume":"30","author":"Koszewicz","year":"2011","journal-title":"Int Angiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jopan.2010.05.012","article-title":"Perianesthesia Management of Raynauds Phenomenon-A Case Report.","volume":"25","author":"Liang","year":"2010","journal-title":"J PeriAnesthesia Nurs"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.annder.2011.09.006","article-title":"Digital ulcers in systemic scleroderma. Pre-test.","volume":"138","author":"Lok","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.annder.2011.06.011","article-title":"Digital ulcers in systemic scleroderma.","volume":"138","author":"Lok","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1346-8138.2011.01299.x","article-title":"Bosentan for digital ulcers in patients with systemic sclerosis.","volume":"39","author":"Nagai","year":"2012","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1346-8138.2011.01357.x","article-title":"Dermoscopic detection of nail fold capillary abnormality in patients with systemic sclerosis.","volume":"39","author":"Ohtsuka","year":"2012","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3899\/jrheum.101129","article-title":"Raynauds Phenomenon in Medical Laboratory Workers Who Work with Solvents.","volume":"38","author":"Purdie","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","first-page":"34","article-title":"Management of digital ulcers in patients with systemic sclerosis.","volume":"137","author":"Riemekasten","year":"2012","journal-title":"Dtsch Med Wochenschr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejim.2010.09.013","article-title":"Erectile dysfunction of sclerodermic patients correlates with digital vascular damage.","volume":"22","author":"Rosato","year":"2011","journal-title":"Eur J Intern Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"H324","DOI":"10.1152\/ajpheart.00246.2011","article-title":"Impaired transient vasodilation and increased vasoconstriction to digital local cooling in primary Raynauds phenomenon.","volume":"301","author":"Roustit","year":"2011","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/clpt.2011.302","article-title":"Sildenafil Increases Digital Skin Blood Flow During All Phases of Local Cooling in Primary Raynauds Phenomenon.","volume":"91","author":"Roustit","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3899\/jrheum.110067","article-title":"Effects of Iloprost on Microvascular Structure Assessed by Nailfold Videocapillaroscopy: A Pilot Study.","volume":"38","author":"Shah","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ddr.20486","article-title":"Potential for phosphodiesterase inhibitors in the management of autoimmune diseases.","volume":"72","author":"Shenoy","year":"2011","journal-title":"Drug Dev Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3899\/jrheum.110793","article-title":"Clinical Significance of Cryofibrinogenemia: Possible Pathophysiological Link with Raynauds Phenomenon.","volume":"39","author":"Soyfoo","year":"2012","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1113\/jphysiol.2011.215020","article-title":"Effects of cyclooxygenase inhibition on vascular responses evoked in fingers of men and women by iontophoresis of alpha(1)- and alpha(2)-adrenoceptor agonists.","volume":"589","author":"Srinivasa","year":"2011","journal-title":"J Physiol-London"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1524-4725.2011.02093.x","article-title":"Scleroderma and Raynauds Phenomenon Improve with High-Peak Power Laser Therapy: A Case Report.","volume":"37","author":"St Surin-Lord S, Obagi","year":"2011","journal-title":"Dermatol Surg"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/art.33463","article-title":"Timing of transition between capillaroscopic patterns in systemic sclerosis.","volume":"64","author":"Sulli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.healun.2011.12.011","article-title":"Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referral.","volume":"31","author":"Badagliacca","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1755-5922.2011.00279.x","article-title":"ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension.","volume":"30","author":"Badesch","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension.","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in Childhood Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management.","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cvr\/cvr356","article-title":"Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.","volume":"93","author":"Bauer","year":"2012","journal-title":"Cardiovasc Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejim.2011.02.005","article-title":"Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.","volume":"22","author":"Caravita","year":"2011","journal-title":"Eur J Intern Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/RCT.0b013e31824afbdf","article-title":"Multidetector Computed Tomography for Detection and Characterization of Pulmonary Hypertension in Consideration of WHO Classification.","volume":"36","author":"Dornia","year":"2012","journal-title":"J Comput Assist Tomogr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.hrtlng.2011.05.007","article-title":"The experiences of patients with pulmonary. arterial hypertension receiving continuous intravenous infusion of epoprostenol (Flolan) and their support persons.","volume":"41","author":"Hall","year":"2012","journal-title":"Heart Lung"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1536\/ihj.52.233","article-title":"Acute Effect of Sildenafil Is Maintained in Pulmonary Arterial Hypertension Patients Chronically Treated With Bosentan.","volume":"52","author":"Hatano","year":"2011","journal-title":"Int Heart J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","article-title":"Survival in scleroderma: results from the population-based South Australian Register.","volume":"41","author":"Hissaria","year":"2011","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12012-011-9137-8","article-title":"Effects of Everolimus in Combination with Sildenafil in Monocrotaline-induced Pulmonary Hypertension in Rats.","volume":"12","author":"Ilgin","year":"2012","journal-title":"Cardiovasc Toxicol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study.","volume":"31","author":"Kemp","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/clc.20920","article-title":"Right Ventricular Systolic Pressure Assessed by Echocardiography: A Predictive Factor of Mortality in Patients With Scleroderma.","volume":"34","author":"Kiatchoosakun","year":"2011","journal-title":"Clin Cardiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.echo.2011.11.007","article-title":"Right-Heart Function Related to the Results of Acute Pulmonary Vasodilator Testing in Patients with Pulmonary Arterial Hypertension Caused by Connective Tissue Disease.","volume":"25","author":"Liu","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-11-1175","article-title":"Effects of Autologous Bone Marrow Mononuclear Cells Implantation in Canine Model of Pulmonary Hypertension.","volume":"76","author":"Luan","year":"2012","journal-title":"Circ J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3899\/jrheum.110512","article-title":"Tricuspid Annular Plane Systolic Excursion Is a Robust Outcome Measure in Systemic Sclerosis-associated Pulmonary Arterial Hypertension.","volume":"38","author":"Mathai","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MAJ.0b013e3181f0b0b4","article-title":"Scleroderma: The Need for Extreme Remedies.","volume":"342","author":"Olsen","year":"2011","journal-title":"Am J Med Sci"},{"key":"-20210128","first-page":"357","article-title":"Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice Clin R","volume":"31","author":"Pauling","year":"2012","journal-title":"heumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0091270011398241","article-title":"Oral Sildenafil Therapy for Chinese Patients With Pulmonary Arterial Hypertension: A Multicenter Study.","volume":"52","author":"Xiong","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1253\/circj.CJ-11-1192","article-title":"Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension.","volume":"76","author":"Yanagisawa","year":"2012","journal-title":"Circ J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/acr.20591","article-title":"Validity of Two New Patient-Reported Outcome Measures in Systemic Sclerosis: Patient-Reported Outcomes Measurement Information System 29-Item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea Short Form.","volume":"63","author":"Hinchcliff","year":"2011","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpsychores.2011.12.005","article-title":"Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem.","volume":"72","author":"Kwakkenbos","year":"2012","journal-title":"J Psychosomat Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/acr.20696","article-title":"Rates and correlates of sexual activity and impairment among women with systemic sclerosis.","volume":"64","author":"Levis","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2133.2011.10624.x","article-title":"Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.","volume":"166","author":"Muller","year":"2012","journal-title":"Br J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/acr.20598","article-title":"Measures of Systemic Sclerosis (Scleroderma) Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician- and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahlers Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynauds Condition Score (RCS).","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/acr.20676","article-title":"Work productivity in scleroderma: Analysis from the University of California, Los Angeles scleroderma quality of life study.","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-011-1785-3","article-title":"Depression among the Moroccan systemic sclerosis.","volume":"31","author":"Wafki","year":"2012","journal-title":"Clin Rheumatol"},{"key":"-20210128","first-page":"8","article-title":"J Invest M","volume":"60","year":"2012","journal-title":"ed"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jcp.22520","article-title":"Decreased Secretion of MMP by Non-Lesional Late-Stage Scleroderma Fibroblasts After Selection Via Activation of the Apoptotic Fas-Pathway.","volume":"226","author":"Chabaud","year":"2011","journal-title":"J Cell Physiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.1100876","article-title":"TGF-beta-Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts.","volume":"188","author":"Honda","year":"2012","journal-title":"J Immunol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajpath.2011.10.030","article-title":"Increased Accumulation of Extracellular Thrombospondin-2 Due to Low Degradation Activity Stimulates Type I Collagen Expression in Scleroderma Fibroblasts.","volume":"180","author":"Kajihara","year":"2012","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/jid.2012.67","article-title":"Toward Personalized Medicine in Scleroderma: Classification of Scleroderma Patients into Stable Inflammatory and Fibrotic Subgroups.","volume":"132","author":"Leask","year":"2012","journal-title":"J Invest Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/jcp.22690","article-title":"Endoglin Promotes TGF-betaSmad1 Signaling in Scleroderma Fibroblasts.","volume":"226","author":"Morris","year":"2011","journal-title":"J Cell Physiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts.","volume":"188","author":"Nakashima","year":"2012","journal-title":"J Immunol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2011.07.044","article-title":"Curcumin suppresses TGF-beta signaling by inhibition of TGIF degradation in scleroderma fibroblasts.","volume":"411","author":"Song","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1365-2133.2011.10243.x","article-title":"A case of taxane-induced scleroderma: a different expression profile of Fli1 proteins in dermal fibroblasts and microvascular endothelial cells compared with systemic sclerosis.","volume":"164","author":"Takahashi","year":"2011","journal-title":"Br J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3435","article-title":"Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts - art. no. R128.","volume":"13","author":"Zhou","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2474-13-11","article-title":"Pressure and pain In Systemic sclerosisScleroderma - an evaluation of a simple intervention (PISCES): randomised controlled trial protocol - art. no. 11.","volume":"13","author":"Alcacer-Pitarch","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1684\/ejd.2011.1451","article-title":"Fingertip calcinosis cutis in an incomplete limited-type systemic scleroderma.","volume":"21","author":"Ales-Fernandez","year":"2011","journal-title":"Eur J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3949\/ccjm.78a.11014","article-title":"The Clinical Picture A less common source of dyspnea in scleroderma.","volume":"78","author":"Altahawi","year":"2011","journal-title":"Clevel Clin J Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1259\/dmfr\/64340754","article-title":"Early diagnosis of progressive systemic sclerosis (scleroderma) from a panoramic view: report of three cases.","volume":"40","author":"Anbiaee","year":"2011","journal-title":"Dentomaxillofac Radiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0022-3859.93254","article-title":"Anti-myelin-associated glycoprotein polyneuropathy coexistent with CREST syndrome.","volume":"58","author":"Andreadou","year":"2012","journal-title":"J Postgrad Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1600-0625.2011.01310.x","article-title":"Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"key":"-20210128","first-page":"S15","article-title":"Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.","volume":"29","author":"Bae","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1445-5994.2011.02557.x","article-title":"Pneumatosis cystoides intestinalis in scleroderma-related conditions.","volume":"42","author":"Balbir-Gurman","year":"2012","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3899\/jrheum.110060","article-title":"Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument Version 2. 0 for Systemic Sclerosis (vol 38, pg 1925, 2011).","volume":"38","author":"Baron","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3899\/jrheum.110060","article-title":"Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument Version 2.0 for Systemic Sclerosis.","volume":"38","author":"Baron","year":"2011","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2010.142489","article-title":"EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"-20210128","first-page":"8","article-title":"J Invest M","volume":"60","year":"2012","journal-title":"ed"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4161\/cc.10.13.16227","article-title":"Scleroderma-like properties of skin from caveolin-1-deficient mice Implications for new treatment strategies in patients with fibrosis and systemic sclerosis.","volume":"10","author":"Castello-Cros","year":"2011","journal-title":"Cell Cycle"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/14764172.2012.672744","article-title":"Improvement of microstomia in scleroderma after intense pulsed light: A case series of four patients.","volume":"14","author":"Comstedt","year":"2012","journal-title":"J Cosmet Laser Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1183\/09031936.00174910","article-title":"Significance of connective tissue disease features in idiopathic interstitial pneumonia.","volume":"39","author":"Corte","year":"2012","journal-title":"Eur Resp J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10067-010-1653-6","article-title":"Sonographically guided hydrodissection and corticosteroid injection for scleroderma hand.","volume":"30","author":"De Lea","year":"2011","journal-title":"Clin Rheumatol"},{"key":"-20210128","first-page":"3629","article-title":"Caveolin-1: A new therapeutic target in tissue fibrosis and scleroderma Cell C","volume":"10","author":"Del Galdo","year":"2011","journal-title":"ycle"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma (vol 70, pg 104, 2011).","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10067-011-1744-z","article-title":"Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients.","volume":"30","author":"Foocharoen","year":"2011","journal-title":"Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/acr.20679","article-title":"Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.","volume":"64","author":"Fransen","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","first-page":"487","article-title":"Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis.","volume":"25","author":"Giordano","year":"2011","journal-title":"J Biol Regul Homeost Agents"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/RHU.0b013e31824a4d4b","article-title":"Prepatellar and Preolecranon Subcutaneous Calcifications in Scleroderma.","volume":"18","author":"Gonzalez","year":"2012","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RHU.0b013e31824a4d4b","article-title":"Prepatellar and Preolecranon Subcutaneous Calcifications in Scleroderma (vol 18, pg 211, 2012).","volume":"18","author":"Gonzalez","year":"2012","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","article-title":"Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets.","volume":"180","author":"Greenblatt","year":"2012","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.arcped.2011.11.005","article-title":"Distal synovitis with scleroderma-like skin lesions.","volume":"19","author":"Hamdi","year":"2012","journal-title":"Arch Pediatr"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.cca.2011.08.024","article-title":"Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.","volume":"412","author":"Hamdouch","year":"2011","journal-title":"Clin Chim Acta"},{"key":"-20210128","first-page":"76","article-title":"Primary scleroderma myocardial disease DISCUSSION.","volume":"195","author":"Hauw","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/rheum.111133","article-title":"Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis.","volume":"39","author":"Hudson","year":"2012","journal-title":"J Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1346-8138.2011.01301.x","article-title":"Case of bleomycin-induced scleroderma.","volume":"39","author":"Inaoki","year":"2012","journal-title":"J Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2169\/internalmedicine.50.5653","article-title":"Thrombotic Thrombocytopenic Purpura with Severe Hypertension in a Patient with Systemic Sclerosis Sine Scleroderma and Polymyositis.","volume":"50","author":"Iwagami","year":"2011","journal-title":"Intern Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20684","article-title":"Validation of potential classification criteria for systemic sclerosis.","volume":"64","author":"Johnson","year":"2012","journal-title":"Arthritis Care Res"},{"key":"-20210128","first-page":"69","article-title":"Primary scleroderma myocardial disease.","volume":"195","author":"Kahan","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajpath.2011.09.013","article-title":"Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma.","volume":"180","author":"Kitaba","year":"2012","journal-title":"Am J Pathol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/jid.2012.67","article-title":"Toward Personalized Medicine in Scleroderma: Classification of Scleroderma Patients into Stable Inflammatory and Fibrotic Subgroups.","volume":"132","author":"Leask","year":"2012","journal-title":"J Invest Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features - art. no. R172.","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/art.30283","article-title":"Systemic Sclerosis Is an Independent Risk Factor for Increased Coronary Artery Calcium Deposition.","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Rheum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0625.2011.01419.x","article-title":"Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.","volume":"21","author":"Nakamura-Wakatsuki","year":"2012","journal-title":"Exp Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar3445","article-title":"Cardiovascular disease in systemic sclerosis - an emerging association - art. no. 237.","volume":"13","author":"Ngian","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort - art. no. R211.","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2230.2011.04201.x","article-title":"Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.","volume":"37","author":"Ozgen","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1016\/j.ijcard.2009.03.080","article-title":"Atrial flutter, ventricular tachycardia and changing axis deviation associated with scleroderma.","volume":"153","author":"Patane","year":"2011","journal-title":"Int J Cardiol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clindermatol.2011.01.019","article-title":"Cutaneous signs of systemic disease.","volume":"29","author":"Patel","year":"2011","journal-title":"Clin Dermatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhsa.2011.12.030","article-title":"Nonoperative Management of Scleroderma of the Hand With Tadalafil and Subatmospheric Pressure Wound Therapy: Case Report.","volume":"37A","author":"Patel","year":"2012","journal-title":"J Hand Surg-Am Vol"},{"key":"-20210128","first-page":"337","article-title":"Helicobacter pylori infection and systemic sclerosis-is there a link Joint Bone S","volume":"78","author":"Radic","year":"2011","journal-title":"pine"},{"key":"-20210128","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1445-5994.2011.02706.x","article-title":"Stochastic processes in the aetiopathogenesis of scleroderma.","volume":"42","author":"Roberts-Thomson","year":"2012","journal-title":"Intern Med J"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RHU.0b013e31823ee767","article-title":"Calcinosis Universalis in a Patient With Overlap of SclerodermaDermatomyositis.","volume":"18","author":"Shenavandeh","year":"2012","journal-title":"JCR-J Clin Rheumatol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/19338244.2011.564231","article-title":"Pesticide-Induced Scleroderma and Early Intensive Immunosuppressive Treatment.","volume":"67","author":"Sozeri","year":"2012","journal-title":"Arch Environ Occup Health"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1016\/j.ejim.2011.05.007","article-title":"Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.","volume":"22","author":"Trad","year":"2011","journal-title":"Eur J Intern Med"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/ar3510","article-title":"Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study - art. no. R183.","volume":"13","author":"van Wyk","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000329024","article-title":"Irradiation with Water-Filtered Infrared A plus Visible Light Improves Cutaneous Scleroderma Lesions in a Series of Cases.","volume":"222","author":"von Felbert","year":"2011","journal-title":"Dermatology"},{"key":"-20210128","first-page":"1707","article-title":"Canonical Wnt Signaling Induces Skin Fibrosis and Subcutaneous Lipoatrophy A Novel Mouse Model for Scleroderma Arthritis R","volume":"63","author":"Wei","year":"2011","journal-title":"heum"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jfo.2011.09.008","article-title":"Eyelid necrosis after injection of lidocaine with epinephrine.","volume":"35","author":"Yakoubi","year":"2012","journal-title":"J Fr Ophthamol"},{"key":"-20210128","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1002\/art.30470","article-title":"The Specific Free Radical Scavenger Edaravone Suppresses Fibrosis in the Bleomycin-Induced and Tight Skin Mouse Models of Systemic Sclerosis.","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e328359ee5b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:02:28Z","timestamp":1643479348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201211000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":364,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328359ee5b","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}